nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—SLC22A1—Estropipate—osteoporosis	0.397	0.531	CbGbCtD
Vecuronium—SLC22A1—Estradiol—osteoporosis	0.165	0.22	CbGbCtD
Vecuronium—ABCB1—Ethinyl Estradiol—osteoporosis	0.0785	0.105	CbGbCtD
Vecuronium—ABCB1—Conjugated Estrogens—osteoporosis	0.0576	0.0769	CbGbCtD
Vecuronium—ABCB1—Estradiol—osteoporosis	0.0506	0.0675	CbGbCtD
Vecuronium—Drug ineffective—Estradiol—osteoporosis	0.0116	0.0461	CcSEcCtD
Vecuronium—Redness—Ibandronate—osteoporosis	0.00539	0.0215	CcSEcCtD
Vecuronium—Redness—Calcitriol—osteoporosis	0.00528	0.021	CcSEcCtD
Vecuronium—Rash erythematous—Ibandronate—osteoporosis	0.00475	0.0189	CcSEcCtD
Vecuronium—Injection site pain—Ibandronate—osteoporosis	0.00446	0.0178	CcSEcCtD
Vecuronium—Redness—Pamidronate—osteoporosis	0.00422	0.0168	CcSEcCtD
Vecuronium—Redness—Zoledronate—osteoporosis	0.00386	0.0154	CcSEcCtD
Vecuronium—Injection site reaction—Ibandronate—osteoporosis	0.00362	0.0144	CcSEcCtD
Vecuronium—Redness—Estradiol—osteoporosis	0.00297	0.0118	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Estropipate—osteoporosis	0.00285	0.0113	CcSEcCtD
Vecuronium—Rash erythematous—Estradiol—osteoporosis	0.00262	0.0104	CcSEcCtD
Vecuronium—Injection site reaction—Zoledronate—osteoporosis	0.00259	0.0103	CcSEcCtD
Vecuronium—Face oedema—Ibandronate—osteoporosis	0.00255	0.0102	CcSEcCtD
Vecuronium—Shock—Calcium Acetate—osteoporosis	0.00235	0.00935	CcSEcCtD
Vecuronium—Bronchospasm—Ibandronate—osteoporosis	0.00225	0.00895	CcSEcCtD
Vecuronium—Hypotension—Calcium Acetate—osteoporosis	0.00223	0.00888	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Pamidronate—osteoporosis	0.00214	0.00852	CcSEcCtD
Vecuronium—Muscular weakness—Risedronate—osteoporosis	0.00192	0.00765	CcSEcCtD
Vecuronium—Erythema—Etidronic acid—osteoporosis	0.00192	0.00764	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.00188	0.00749	CcSEcCtD
Vecuronium—Connective tissue disorder—Raloxifene—osteoporosis	0.00181	0.00723	CcSEcCtD
Vecuronium—Connective tissue disorder—Ibandronate—osteoporosis	0.0018	0.00716	CcSEcCtD
Vecuronium—Cardiac disorder—Estropipate—osteoporosis	0.00177	0.00705	CcSEcCtD
Vecuronium—Bronchospasm—Pamidronate—osteoporosis	0.00176	0.00701	CcSEcCtD
Vecuronium—Hypersensitivity—Calcium Acetate—osteoporosis	0.00176	0.007	CcSEcCtD
Vecuronium—Angioedema—Etidronic acid—osteoporosis	0.00175	0.00698	CcSEcCtD
Vecuronium—Angiopathy—Estropipate—osteoporosis	0.00173	0.00689	CcSEcCtD
Vecuronium—Immune system disorder—Estropipate—osteoporosis	0.00172	0.00686	CcSEcCtD
Vecuronium—Mediastinal disorder—Estropipate—osteoporosis	0.00172	0.00684	CcSEcCtD
Vecuronium—Flushing—Raloxifene—osteoporosis	0.00171	0.00683	CcSEcCtD
Vecuronium—Cardiac disorder—Raloxifene—osteoporosis	0.00171	0.00683	CcSEcCtD
Vecuronium—Cardiac disorder—Ibandronate—osteoporosis	0.0017	0.00676	CcSEcCtD
Vecuronium—Angiopathy—Raloxifene—osteoporosis	0.00167	0.00667	CcSEcCtD
Vecuronium—Muscular weakness—Zoledronate—osteoporosis	0.00167	0.00664	CcSEcCtD
Vecuronium—Erythema—Estropipate—osteoporosis	0.00166	0.00661	CcSEcCtD
Vecuronium—Angiopathy—Ibandronate—osteoporosis	0.00166	0.00661	CcSEcCtD
Vecuronium—Immune system disorder—Ibandronate—osteoporosis	0.00165	0.00658	CcSEcCtD
Vecuronium—Mediastinal disorder—Ibandronate—osteoporosis	0.00165	0.00656	CcSEcCtD
Vecuronium—Erythema—Alendronate—osteoporosis	0.00163	0.00651	CcSEcCtD
Vecuronium—Bronchospasm—Zoledronate—osteoporosis	0.00161	0.0064	CcSEcCtD
Vecuronium—Erythema—Ibandronate—osteoporosis	0.00159	0.00634	CcSEcCtD
Vecuronium—Erythema—Calcitriol—osteoporosis	0.00156	0.00621	CcSEcCtD
Vecuronium—Bronchospasm—Conjugated Estrogens—osteoporosis	0.00155	0.00617	CcSEcCtD
Vecuronium—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.00152	0.00605	CcSEcCtD
Vecuronium—Angioedema—Estropipate—osteoporosis	0.00152	0.00604	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Estradiol—osteoporosis	0.00151	0.006	CcSEcCtD
Vecuronium—Angioedema—Alendronate—osteoporosis	0.00149	0.00595	CcSEcCtD
Vecuronium—Connective tissue disorder—Risedronate—osteoporosis	0.00148	0.0059	CcSEcCtD
Vecuronium—Angioedema—Ibandronate—osteoporosis	0.00145	0.00579	CcSEcCtD
Vecuronium—Connective tissue disorder—Pamidronate—osteoporosis	0.00141	0.00561	CcSEcCtD
Vecuronium—Face oedema—Estradiol—osteoporosis	0.00141	0.0056	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.0014	0.00559	CcSEcCtD
Vecuronium—Angiopathy—Ethinyl Estradiol—osteoporosis	0.0014	0.00558	CcSEcCtD
Vecuronium—Cardiac disorder—Risedronate—osteoporosis	0.0014	0.00557	CcSEcCtD
Vecuronium—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.0014	0.00556	CcSEcCtD
Vecuronium—Angiopathy—Risedronate—osteoporosis	0.00137	0.00545	CcSEcCtD
Vecuronium—Immune system disorder—Risedronate—osteoporosis	0.00136	0.00542	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00136	0.00541	CcSEcCtD
Vecuronium—Mediastinal disorder—Risedronate—osteoporosis	0.00136	0.00541	CcSEcCtD
Vecuronium—Anaphylactic shock—Estropipate—osteoporosis	0.00135	0.0054	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00135	0.00536	CcSEcCtD
Vecuronium—Flushing—Pamidronate—osteoporosis	0.00133	0.00529	CcSEcCtD
Vecuronium—Cardiac disorder—Pamidronate—osteoporosis	0.00133	0.00529	CcSEcCtD
Vecuronium—Nervous system disorder—Estropipate—osteoporosis	0.00133	0.00529	CcSEcCtD
Vecuronium—Skin disorder—Estropipate—osteoporosis	0.00132	0.00524	CcSEcCtD
Vecuronium—Angiopathy—Pamidronate—osteoporosis	0.0013	0.00518	CcSEcCtD
Vecuronium—Anaphylactic shock—Ibandronate—osteoporosis	0.0013	0.00517	CcSEcCtD
Vecuronium—Immune system disorder—Pamidronate—osteoporosis	0.00129	0.00515	CcSEcCtD
Vecuronium—Mediastinal disorder—Pamidronate—osteoporosis	0.00129	0.00514	CcSEcCtD
Vecuronium—Shock—Raloxifene—osteoporosis	0.00129	0.00514	CcSEcCtD
Vecuronium—Nervous system disorder—Raloxifene—osteoporosis	0.00129	0.00513	CcSEcCtD
Vecuronium—Connective tissue disorder—Zoledronate—osteoporosis	0.00129	0.00512	CcSEcCtD
Vecuronium—Shock—Ibandronate—osteoporosis	0.00128	0.00509	CcSEcCtD
Vecuronium—Skin disorder—Raloxifene—osteoporosis	0.00127	0.00508	CcSEcCtD
Vecuronium—Nervous system disorder—Ibandronate—osteoporosis	0.00127	0.00507	CcSEcCtD
Vecuronium—Anaphylactic shock—Calcitriol—osteoporosis	0.00127	0.00506	CcSEcCtD
Vecuronium—Skin disorder—Ibandronate—osteoporosis	0.00126	0.00503	CcSEcCtD
Vecuronium—Erythema—Pamidronate—osteoporosis	0.00125	0.00497	CcSEcCtD
Vecuronium—Urticaria—Etidronic acid—osteoporosis	0.00124	0.00495	CcSEcCtD
Vecuronium—Bronchospasm—Estradiol—osteoporosis	0.00124	0.00494	CcSEcCtD
Vecuronium—Skin disorder—Calcitriol—osteoporosis	0.00123	0.00492	CcSEcCtD
Vecuronium—Angioedema—Ethinyl Estradiol—osteoporosis	0.00123	0.0049	CcSEcCtD
Vecuronium—Cardiac disorder—Zoledronate—osteoporosis	0.00121	0.00484	CcSEcCtD
Vecuronium—Flushing—Zoledronate—osteoporosis	0.00121	0.00484	CcSEcCtD
Vecuronium—Angioedema—Risedronate—osteoporosis	0.0012	0.00477	CcSEcCtD
Vecuronium—Angiopathy—Zoledronate—osteoporosis	0.00119	0.00473	CcSEcCtD
Vecuronium—Immune system disorder—Zoledronate—osteoporosis	0.00118	0.00471	CcSEcCtD
Vecuronium—Mediastinal disorder—Zoledronate—osteoporosis	0.00118	0.0047	CcSEcCtD
Vecuronium—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00117	0.00466	CcSEcCtD
Vecuronium—Hypersensitivity—Etidronic acid—osteoporosis	0.00115	0.00459	CcSEcCtD
Vecuronium—Angiopathy—Conjugated Estrogens—osteoporosis	0.00114	0.00455	CcSEcCtD
Vecuronium—Angioedema—Pamidronate—osteoporosis	0.00114	0.00454	CcSEcCtD
Vecuronium—Erythema—Zoledronate—osteoporosis	0.00114	0.00454	CcSEcCtD
Vecuronium—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00114	0.00453	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00114	0.00453	CcSEcCtD
Vecuronium—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00113	0.00452	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00111	0.00442	CcSEcCtD
Vecuronium—Erythema—Conjugated Estrogens—osteoporosis	0.0011	0.00437	CcSEcCtD
Vecuronium—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00108	0.00429	CcSEcCtD
Vecuronium—Urticaria—Estropipate—osteoporosis	0.00108	0.00429	CcSEcCtD
Vecuronium—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00107	0.00425	CcSEcCtD
Vecuronium—Urticaria—Alendronate—osteoporosis	0.00106	0.00422	CcSEcCtD
Vecuronium—Shock—Risedronate—osteoporosis	0.00105	0.00419	CcSEcCtD
Vecuronium—Nervous system disorder—Risedronate—osteoporosis	0.00105	0.00418	CcSEcCtD
Vecuronium—Angioedema—Zoledronate—osteoporosis	0.00104	0.00415	CcSEcCtD
Vecuronium—Skin disorder—Risedronate—osteoporosis	0.00104	0.00414	CcSEcCtD
Vecuronium—Urticaria—Ibandronate—osteoporosis	0.00103	0.00411	CcSEcCtD
Vecuronium—Anaphylactic shock—Pamidronate—osteoporosis	0.00102	0.00405	CcSEcCtD
Vecuronium—Urticaria—Calcitriol—osteoporosis	0.00101	0.00402	CcSEcCtD
Vecuronium—Angioedema—Conjugated Estrogens—osteoporosis	0.001	0.00399	CcSEcCtD
Vecuronium—Shock—Pamidronate—osteoporosis	0.001	0.00399	CcSEcCtD
Vecuronium—Hypersensitivity—Estropipate—osteoporosis	0.000998	0.00398	CcSEcCtD
Vecuronium—Nervous system disorder—Pamidronate—osteoporosis	0.000998	0.00397	CcSEcCtD
Vecuronium—Tachycardia—Pamidronate—osteoporosis	0.000993	0.00396	CcSEcCtD
Vecuronium—Connective tissue disorder—Estradiol—osteoporosis	0.00099	0.00395	CcSEcCtD
Vecuronium—Rash—Etidronic acid—osteoporosis	0.000987	0.00393	CcSEcCtD
Vecuronium—Dermatitis—Etidronic acid—osteoporosis	0.000986	0.00393	CcSEcCtD
Vecuronium—Hypersensitivity—Alendronate—osteoporosis	0.000983	0.00392	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000963	0.00384	CcSEcCtD
Vecuronium—Hypersensitivity—Ibandronate—osteoporosis	0.000957	0.00381	CcSEcCtD
Vecuronium—Hypotension—Pamidronate—osteoporosis	0.00095	0.00379	CcSEcCtD
Vecuronium—Hypersensitivity—Calcitriol—osteoporosis	0.000936	0.00373	CcSEcCtD
Vecuronium—Cardiac disorder—Estradiol—osteoporosis	0.000935	0.00373	CcSEcCtD
Vecuronium—Flushing—Estradiol—osteoporosis	0.000935	0.00373	CcSEcCtD
Vecuronium—Anaphylactic shock—Zoledronate—osteoporosis	0.000929	0.0037	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000927	0.00369	CcSEcCtD
Vecuronium—Angiopathy—Estradiol—osteoporosis	0.000914	0.00364	CcSEcCtD
Vecuronium—Shock—Zoledronate—osteoporosis	0.000914	0.00364	CcSEcCtD
Vecuronium—Nervous system disorder—Zoledronate—osteoporosis	0.000911	0.00363	CcSEcCtD
Vecuronium—Immune system disorder—Estradiol—osteoporosis	0.00091	0.00363	CcSEcCtD
Vecuronium—Mediastinal disorder—Estradiol—osteoporosis	0.000908	0.00362	CcSEcCtD
Vecuronium—Tachycardia—Zoledronate—osteoporosis	0.000907	0.00361	CcSEcCtD
Vecuronium—Skin disorder—Zoledronate—osteoporosis	0.000902	0.0036	CcSEcCtD
Vecuronium—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000895	0.00357	CcSEcCtD
Vecuronium—Shock—Conjugated Estrogens—osteoporosis	0.00088	0.00351	CcSEcCtD
Vecuronium—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000877	0.0035	CcSEcCtD
Vecuronium—Erythema—Estradiol—osteoporosis	0.000877	0.0035	CcSEcCtD
Vecuronium—Tachycardia—Conjugated Estrogens—osteoporosis	0.000873	0.00348	CcSEcCtD
Vecuronium—Urticaria—Ethinyl Estradiol—osteoporosis	0.000872	0.00347	CcSEcCtD
Vecuronium—Skin disorder—Conjugated Estrogens—osteoporosis	0.000869	0.00346	CcSEcCtD
Vecuronium—Hypotension—Zoledronate—osteoporosis	0.000868	0.00346	CcSEcCtD
Vecuronium—Rash—Estropipate—osteoporosis	0.000854	0.0034	CcSEcCtD
Vecuronium—Dermatitis—Estropipate—osteoporosis	0.000853	0.0034	CcSEcCtD
Vecuronium—Urticaria—Risedronate—osteoporosis	0.00085	0.00339	CcSEcCtD
Vecuronium—Rash—Alendronate—osteoporosis	0.000841	0.00335	CcSEcCtD
Vecuronium—Dermatitis—Alendronate—osteoporosis	0.00084	0.00335	CcSEcCtD
Vecuronium—Hypotension—Conjugated Estrogens—osteoporosis	0.000836	0.00333	CcSEcCtD
Vecuronium—Rash—Raloxifene—osteoporosis	0.000827	0.0033	CcSEcCtD
Vecuronium—Dermatitis—Raloxifene—osteoporosis	0.000826	0.00329	CcSEcCtD
Vecuronium—Rash—Ibandronate—osteoporosis	0.000819	0.00326	CcSEcCtD
Vecuronium—Dermatitis—Ibandronate—osteoporosis	0.000818	0.00326	CcSEcCtD
Vecuronium—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000809	0.00322	CcSEcCtD
Vecuronium—Angioedema—Estradiol—osteoporosis	0.000802	0.00319	CcSEcCtD
Vecuronium—Rash—Calcitriol—osteoporosis	0.000801	0.00319	CcSEcCtD
Vecuronium—Dermatitis—Calcitriol—osteoporosis	0.000801	0.00319	CcSEcCtD
Vecuronium—Hypersensitivity—Risedronate—osteoporosis	0.000788	0.00314	CcSEcCtD
Vecuronium—Hypersensitivity—Pamidronate—osteoporosis	0.000749	0.00299	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000742	0.00296	CcSEcCtD
Vecuronium—Urticaria—Zoledronate—osteoporosis	0.000738	0.00294	CcSEcCtD
Vecuronium—Anaphylactic shock—Estradiol—osteoporosis	0.000716	0.00285	CcSEcCtD
Vecuronium—Urticaria—Conjugated Estrogens—osteoporosis	0.000711	0.00283	CcSEcCtD
Vecuronium—Shock—Estradiol—osteoporosis	0.000704	0.00281	CcSEcCtD
Vecuronium—Nervous system disorder—Estradiol—osteoporosis	0.000702	0.0028	CcSEcCtD
Vecuronium—Tachycardia—Estradiol—osteoporosis	0.000699	0.00278	CcSEcCtD
Vecuronium—Skin disorder—Estradiol—osteoporosis	0.000695	0.00277	CcSEcCtD
Vecuronium—Rash—Ethinyl Estradiol—osteoporosis	0.000692	0.00276	CcSEcCtD
Vecuronium—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000691	0.00275	CcSEcCtD
Vecuronium—Hypersensitivity—Zoledronate—osteoporosis	0.000685	0.00273	CcSEcCtD
Vecuronium—Rash—Risedronate—osteoporosis	0.000675	0.00269	CcSEcCtD
Vecuronium—Dermatitis—Risedronate—osteoporosis	0.000674	0.00269	CcSEcCtD
Vecuronium—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000659	0.00263	CcSEcCtD
Vecuronium—Rash—Pamidronate—osteoporosis	0.000641	0.00256	CcSEcCtD
Vecuronium—Dermatitis—Pamidronate—osteoporosis	0.000641	0.00255	CcSEcCtD
Vecuronium—Rash—Zoledronate—osteoporosis	0.000586	0.00233	CcSEcCtD
Vecuronium—Dermatitis—Zoledronate—osteoporosis	0.000585	0.00233	CcSEcCtD
Vecuronium—Urticaria—Estradiol—osteoporosis	0.000569	0.00227	CcSEcCtD
Vecuronium—Rash—Conjugated Estrogens—osteoporosis	0.000564	0.00225	CcSEcCtD
Vecuronium—Dermatitis—Conjugated Estrogens—osteoporosis	0.000564	0.00225	CcSEcCtD
Vecuronium—Hypersensitivity—Estradiol—osteoporosis	0.000528	0.0021	CcSEcCtD
Vecuronium—Rash—Estradiol—osteoporosis	0.000451	0.0018	CcSEcCtD
Vecuronium—Dermatitis—Estradiol—osteoporosis	0.000451	0.0018	CcSEcCtD
